We are lowering our target price of Bristol Myers despite a profit rate

Bristol Myers Squibb and Rosy Outlook's profits on Thursday did not solve persistent problems for actions. But it was enough,…

Goldman Sachs (GS) Q1 2025 gains

David Solomon, CEO of Goldman Sachs, testifies during an audience of the Senate Banking Committee in the Hart Senate Office…